A case of Basedow's disease, that developed after successful treatment of ulcerative colitis with a total colectomy, is presented, along with a review of the Japanese literature on the coexistence of hyperthyroidism and ulcerative colitis. A 26-year-old man was referred to our department, complaining of general fatigue, appetite loss, and palpitation. At age 14, blood was discovered in his stool and a diagnosis of ulcerative colitis was made. Since then, he has been treated with salazosulfapyridine and prednisolone. On examination, mild exophthalmos and thyroid swelling were observed. Both serum free T3 and T4 levels were increased along with a positive TSHreceptor antibody, while TSH was decreased. Scintigraphic and ultrasonographic examinations of the thyroid gland showed diffuse enlargement. Treatment with thiamazole relieved the symptomsand normalized the thyroid function. Although a high incidence of autoimmunethyroid diseases in association with ulcerative colitis has been suggested, only 6 cases of hyperthyroidism coexisting with ulcerative colitis have been reported in Japan. A common immunological process has been suggested to be implicated in the pathogenesis of this association, however, the exact mechanismremains unclear. (Internal Medicine 40: 44-47, 2001) 
Introduction
Autoimmune thyroid diseases are well known as extraintestinal complications of chronic ulcerative colitis. However, the association of Basedow's disease with ulcerative colitis is very rare. The incidence of thyrotoxicosis in patients with ulcerative colitis has been reported to be from 0.82 (1) to 3.7% (2). On the other hand, the prevalence of ulcerative colitis in patients with hyperthyroidism has been reported as 1.34% (3).
Previous studies in Japan (up to 1 999) have demonstrated only 6 cases of hyperthyroidism in association with chronic ulcerative colitis. In the present report, we describe a case of Basedow's disease which developed 5 years after a successful total colectomy for chronic ulcerative colitis, and present a review of the pertinent Japanese literature.
Case Report
A 26-year-old manwas referred to our department in November 1998 with the chief complaints of general fatigue, appetite loss, and palpitation. His family history was unremarkable. He first passed blood in his stool at age 14, and has since been treated with salazosulfapyridine and prednisolone under a diagnosis of chronic ulcerative colitis (Fig. 1) . During the ensuing years, the patient experienced both remission and exacerbation of the disease. At age 22, he underwent a total colectomy, because of the refractoriness of the disease to conventional medication therapy. He has been taking 15 mg/day of prednisolone for about 10 years. On physical examination, the patient appeared thin and undernourished (height 172 cm, weight 48.0 kg), and had a regular pulse rate of 140 beats per minute, a respiratory rate of 1 9 per minute, and blood pressure of 142/90 mmHg.Mild exophthalmos, swelling of the thyroid gland, and a finger tremor were also observed, with the right lobe of the thyroid gland seen to be larger than the left. Serum free T3 and free T4 were 8.6 pg/ml (normal value: 2.3-3.7 pg/ ml) and 5.2 ng/ml (normal value: 1.0-1.8 ng/ml), respectively.
Thyroid stimulating hormone (TSH) was decreased at a titer of 0.1 1 (lU/ml (normal value: 0.6-5.5 |iU/ml), while TSH antibody (TRAb) (normal<5.0 mU/ml) and thyroid stimulating antibody (TSAb) (normal<180%) were found to be increased above normal (8.7 mU/ml and 256%, respectively). A scintigram and ultrasonogram revealed a diffusely enlarged thyroid gland without definite evidence of nodular lesion. The 24-hour 13II uptake was 54%. The patient was diagnosed with Basedow's disease and treated with thiamazole, after which the symptoms of hyperthyroidism improved. A radiography of the small in-testine with barium meal showed no evidence of relapse of the ulcerative eolitis, although a rectal examination revealed an anal fistula. Data showing a complete blood count and serum biochemistry are summarized in Table 1 . Hematologic laboratory tests showed that the blood chemical values were normal, except for a mild elevation of alkaline phosphatase (Alp) (3 10 U//), alanine aminotransferase (ALT) (5 1 U//), fasting blood sugar (FBS) (1 18 mg/dl), and C-reactive protein (CRP) (2.1 mg/dl). The mild elevation of FBSwas considered to be associated with the long-standing steroid therapy. An immunological examination showed a positive immunecomplex and cryofibrinogen, as well as an increased immunoglobulin E (IgE) concentration (1 ,245 U/ml). The results of the thyroid function tests are summarizedin Table 2 . 
Discussion
There have been several reports on the coexistence of hyperthyroidism and ulcerative colitis (3-5). Someinvestigators have suggested only an incidental association of these two diseases (6, 7), while Jarnerot et al (2) claimed a significant association of hyperthyroidism with ulcerative colitis, when compared with a control group (3.7% vs 0.8%, p<0.01). Jarnerot et al (2) stated that hyperthyroidism should not be regarded as an extraintestinal complication of ulcerative colitis, because hyperthyroidism precedes ulcerative colitis. Onthe other hand, Triantafillidis et al (1) considered that it is an extraintestinal complication of ulcerative colitis, because manyextraintestinal manifestations of ulcerative colitis, such as arthritis and liver disease, are seen before its onset. In Japan, only 6 cases of the coexistence of hyperthyroidism and ulcerative colitis had been reported up to 1999 (Table 3 ) (8-13), comprising two males and four females, with an age range of 30 to 66 years. Twothirds of these cases (4/6) suffered from hyperthyroidism before development of ulcerative colitis. The interval between the manifestation of the two diseases ranged from simultaneous to 20 years. TBG: thyroxin binding globulin (normal 1 2-30 jig/ ml), Anti-Tg-Ab: anti-thyroglobulin antibody (normal<0.7 U/ml), TPO-Ab: thyroperoxidase antibody (normal<0.2 IU/ml), TRAb: TSH receptor antibody (normal<5.0 mU/ml), TSAb: thyroid stimulating antibody (normal<1 80%). In the majority of cases, hyperthyroidism was found to have preceded the development of ulcerative colitis (2, 4). Likewise, it is noteworthy that ulcerative colitis preceded the appearance of Basedow's disease in the present case. Moreover, in most of the other cases, hyperthyroidism developed during the active course of ulcerative colitis or vice versa, suggesting that either one of the diseases in an active stage mayinduce the other (4). In addition, it is suggested that hyperthyroidism in the active stage may cause deterioration of ulcerative colitis, and vice versa. However, in the present case, Basedow's disease developed after a successful total colectomy for ulcerative colitis, and neither double contrast radiography of the small intestine nor fiberscopy of the stomach indicated evidence of an ulcerative colitis relapse at the time of diagnosis of Basedow'sdisease. The hyperthyroidism responded well to conservative treatment with thiamazole. Therefore, as suggested by Goligher et al (6) and Powell et al (7), the possibility of an incidental coexistence of these two diseases in the present case can not be fully excluded. Someassumptions have been madeas to the etiology of both diseases. First, psychological stress seems to exacerbate both (14-16), although one study has claimed that it is not a trigger of either (17) . Second, a genetic etiology may contribute to the coexistence of both diseases. Since the familial occurrence of both diseases has been reported, genetic factors may relate to their coexistence, although humanleukocyte antigen (HLA) typing which is commonin these two diseases has not been described ( 18, 19) . However, the present case possessed HLAAll and negative DPw2, which are considered to be associated with Basedow's disease (18) , and HLA-DR2, which is considered to be associated with ulcerative colitis (19) . Therefore, genetic etiology mayhave some role in the coexistence in the present case. Third, immunologic etiology may also contribute to their coexistence. Thoughthere is no clear explanation for the coexistence of the two diseases, autoimmune processes are assumed in the pathogenesis of both ulcerative colitis and Basedow's disease. Positive immunecomplex and decreased lymphocyte blast formation in ulcerative colitis has been described (20) . In addition, the incidence of positive immunecomplex has been reported to be high in patients with Basedow's disease (21) . Moreover, cases with dermatomyositis (8) or juvenile-onset diabetes mellitus (22) have been described as being associated with these two diseases. Therefore, disturbances in the immunesystem have been implicated in the pathogenesis of ulcerative colitis and Basedow's disease. A positive circulating immunecomplex was observed in the present case as well as in a case in a previous report (9). In addition, an increased serum level of IgE, which mayhave some role in Basedow' s disease (23), along with inflammatory bowel disease (24) and cryofibrinogen were also observed. Therefore, it maybe considered that some humoral/cellular immunologic disturbances associated with ulcerative colitis still exist in the present case, despite the total colectomy and longterm administration of prednisolone. However, it remains unclear as to whether the increased serum IgE concentration, positive immunecomplex, or cryofibrinogen are involved as causative factors in these two diseases. Analysis of many cases will be necessary to clarify the underlying etiology of the coexistence of Basedow's disease and ulcerative colitis. Diarrhea is one of the chief manifestations of both Basedow's disease and ulcerative colitis. Therefore, physicians must take into consideration a complication of Basedow'sdisease when diarrhea persists, despite the favorable course of ulcerative colitis, and vice versa, though this association is rare. Furthermore, a thyroid function test may be required in patients with ulcerative colitis, especially in those who are refractory to conventional therapy, as silent hyperthyroidism in ulcerative colitis has been reported (1 1).
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